Radiographic Position of the Electrode as a Predictor of the Outcome of InterStim Therapy
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Purpose: Sacral neuromodulation (SNM) therapy is indicated for some refractory urological conditions. The electrode lead position in sacral x-rays during routine follow-up may predict the outcome of SNM therapy. To determine whether the radiographic position of the electrode in the sacral foramen predicted the long-term outcome of SNM therapy. Methods: This was a retrospective study of patients who underwent InterStim SNM at Toronto Western Hospital by 2 surgeons from July 2013 to March 2014. The position of electrodes in relation to the sacral bone was assessed on follow-up sacral x-rays. In the lateral view, we determined the location of the radio-opaque marker of the electrode relative to the inner surface of the sacrum (P3, D3, P2, D2, P1, D1, P0, and D0). In the anteroposterior view, the angle between a line through the spinous process shadow and the electrode was measured (0°–30°, 30°–60°, 60°–90°, >90°, or medial). Dissatisfied patients were defined as those who did not improve based on a voiding diary or those who needed salvage treatment after SNM. The primary endpoint was to determine whether the electrode lead position on sacral x-rays predicted the outcome of SNM therapy. Results: A total of 69 patients (61 female and 8 male patients) were included, with a median age of 55 years. Forty-two of the patients (60.9%) had refractory overactive bladder, 21 (30.4%) suffered from chronic urinary retention, and 6 (8.7%) had lower urinary tract symptoms and chronic pelvic pain syndrome. The univariate analysis did not show any correlation between SNM response and the electrode position or angle. Dummy regression analysis using response to implantation as the dependent outcome variable did not show any significance for any of the predictors. Conclusions: Our study did not show a correlation between the long-term response to SNM and the electrode position on follow-up sacral x-rays. In this study, electrode lead position in sacral x-ray at follow-up was not correlated with the outcome of SNM therapy.
Abstract
Purpose: Sacral neuromodulation (SNM) therapy is indicated for some refractory urological conditions. The electrode lead position in sacral x-rays during routine follow-up may predict the outcome of SNM therapy. To determine whether the radiographic position of the electrode in the sacral foramen predicted the long-term outcome of SNM therapy. Methods: This was a retrospective study of patients who underwent InterStim SNM at Toronto Western Hospital by 2 surgeons from July 2013 to March 2014. The position of electrodes in relation to the sacral bone was assessed on follow-up sacral x-rays. In the lateral view, we determined the location of the radio-opaque marker of the electrode relative to the inner surface of the sacrum (P3, D3, P2, D2, P1, D1, P0, and D0). In the anteroposterior view, the angle between a line through the spinous process shadow and the electrode was measured (0°–30°, 30°–60°, 60°–90°, >90°, or medial). Dissatisfied patients were defined as those who did not improve based on a voiding diary or those who needed salvage treatment after SNM. The primary endpoint was to determine whether the electrode lead position on sacral x-rays predicted the outcome of SNM therapy. Results: A total of 69 patients (61 female and 8 male patients) were included, with a median age of 55 years. Forty-two of the patients (60.9%) had refractory overactive bladder, 21 (30.4%) suffered from chronic urinary retention, and 6 (8.7%) had lower urinary tract symptoms and chronic pelvic pain syndrome. The univariate analysis did not show any correlation between SNM response and the electrode position or angle. Dummy regression analysis using response to implantation as the dependent outcome variable did not show any significance for any of the predictors. Conclusions: Our study did not show a correlation between the long-term response to SNM and the electrode position on follow-up sacral x-rays. In this study, electrode lead position in sacral x-ray at follow-up was not correlated with the outcome of SNM therapy.
참고문헌 (20)
- Schmidt RA, "Functional evaluation of sacral nerve root integrity. Report of a technique", Urology, 35, pp.388~392 (1990)
- Noblett KL, "Sacral nerve stimulation for the treatment of refractory voiding and bowel dysfunction", Am J Obstet Gynecol, 210, pp.99~106 (2014)
- van Kerrebroeck PE, "Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study", J Urol, 178, pp.2029~2034 (2007)
- Jonas U, "Efficacy of sacral nerve stimulation for urinary retention : results 18 months after implantation", J Urol, 165, pp.15~19 (2001)
- Hunter C, "Neuromodulation of pelvic visceral pain : review of the literature and case series of potential novel targets for treatment", Pain Pract, 13, pp.3~17 (2013)
- Corcos J, "Prevalence of overactive bladder and incontinence in Canada", Can J Urol, 11, pp.2278~2284 (2004)
- Siegel SW, "Long-term results of a multicenter study on sacral nerve stimulation for treatment of urinary urge incontinence, urgency-frequency, and retention", Urology, 56(6 Suppl 1), pp.87~91 (2000)
- Chapple CR, "Developments in pharmacological therapy for the overactive bladder", BJU Int, 98(Suppl 1), pp.78~87 (2006)
- Andersson KE, "The basis for drug treatment of the overactive bladder", World J Urol, 19, pp.294~298 (2001)
- Jayarajan J, "Pharmacotherapy of overactive bladder in adults: a review of efficacy, tolerability, and quality of life", Res Rep Urol, 6, pp.1~16 (2013)
- Hassouna MM, "Economic evaluation of sacral neuromodulation in overactive bladder : A Canadian perspective", Can Urol Assoc J, 9, pp.242~247 (2015)
- Siegel S, "Results of a prospective, randomized, multicenter study evaluating sacral neuromodulation with InterStim therapy compared to standard medical therapy at 6-months in subjects with mild symptoms of overactive bladder", Neurourol Urodyn, 34, pp.224~230 (2015)
- Dijkema HE, "Neuromodulation of sacral nerves for incontinence and voiding dysfunctions. Clinical results and complications", Eur Urol, 24, pp.72~76 (1993)
- Elabbady AA, "Neural stimulation for chronic voiding dysfunctions", J Urol, 152(6 Pt 1), pp.2076~2080 (1994)
- Thon WF, "Neuromodulation of voiding dysfunction and pelvic pain", World J Urol, 9, pp.138~141 (1991)
- Al-zahrani AA, "Long-term outcome and surgical interventions after sacral neuromodulation implant for lower urinary tract symptoms : 14-year experience at 1 center", J Urol, 185, pp.981~986 (2011)
- Banakhar M, "Topics in neuromodulation treatment", pp.35~62 (2012), InTech
- Jacobs SA, "Randomized prospective crossover study of interstim lead wire placement with curved versus straight stylet", Neurourol Urodyn, 33, pp.488~492 (2014)
- Das AK, "Sacral nerve stimulation for the management of voiding dysfunction", Rev Urol, 2, pp.43~60 (2000)
- Siddiqui NY, "Efficacy and adverse events of sacral nerve stimulation for overactive bladder: a systematic review", Neurourol Urodyn, 29(Suppl 1), pp.S18~S23 (2010)